Jazz Pharmaceuticals (JAZZ) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$3.88
- Estimate
- -$2.38
- Surprise
- -63.4%
- Revenue (period 2026-09-30)
- $1.24B
- Score today
- 6.5/10
Revenue source: xbrl.
How the report landed
Jazz Pharmaceuticals (JAZZ) reported a wider loss than forecast — adjusted EPS of -$3.88 against the -$2.38 estimate (a 63.4% shortfall).
Coverage in the report window
- Jazz Pharmaceuticals Q3 Adj. EPS $(3.88) Misses $(3.86) Estimate, Sales $1.243B Beat $1.208B Estimate — benzinga, 2026-11-02
Where TrendMatrix's rating stands now
TrendMatrix currently rates JAZZ Buy (Wait) at 6.5/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's -63.4% surprise compares with a -8.2% four-quarter average.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Supplier: ESSDS
- Consecutive earnings misses (2)
- News modifier -1: STRONG_BUY_NOW → STRONG_BUY_WAIT
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $214.44
- Entry target
- $209.05
- Price target
- $265.83
- Stop
- $197.13
- Upside to target
- +24.0%
- Reward-to-risk
- 4.2:1
The stock trades at 63.4× trailing but 8.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
JAZZ at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $13.92B
- P/E (fwd)
- 8.2
- P/E (ttm)
- 63.4
- 52-week range
- $128.80–$266.38
- Off 52-week high
- 19.5%
- RSI (14)
- 54
- Volume vs avg
- 1.24×
- Score today
- 6.5/10